Hitachi, NextDocs form partnership in document management solutions for pharmaceutical manufacturers

NewsGuard 100/100 Score

Hitachi, Ltd. (NYSE: HIT / TSE: 6501) and NextDocs Corporation today announced their newly formed partnership in document management solutions for pharmaceutical manufacturers.

“Hitachi has a lot of experience in systems integration for manufacturers, and I’m convinced this partnership will accelerate the adoption of Microsoft Office SharePoint Server in the business areas of Japanese pharmaceutical customers and increase its value Microsoft will continue to create new opportunities with Hitachi.”

Specifically, NextDocs and Hitachi will provide NextDocs Document Management System to the life sciences companies in Japan. NextDocs will provide software licenses and solutions to customers and Hitachi will provide supporting services including business consulting, system integration, training, operation, and validation support for drug regulations. NextDocs will provide necessary support to Hitachi sales, marketing and technical personnel.

Many pharmaceutical companies accelerate globalization of research and development and they must submit applications and receive approval of new drug candidates in the Japan-Europe-U.S. trilateral framework. NextDocs Document Management System is an out-of-the-box software solution which makes it easier to manage trilateral common application documents. It is also compliant with FDA 21 CFR PART 11, which deals with the Food and Drug Administration (FDA) guidelines on electronic records and electronic signatures in the United States. NextDocs Document Management System runs on Microsoft Office SharePoint Server 2007. Customers are able to reduce costs for program development and shorten times for implementation by using NextDocs standard functions and the content management functions of Microsoft SharePoint Server 2007. NextDocs Document Management System has been adopted by over 30 pharmaceutical and medical device companies around the world, and NextDocs continues to gain market share.

Hitachi delivers total solutions for all business processes of pharmaceutical manufacturers such as research and development, production, logistics and sales, and Hitachi has considerable experience especially in regulation consulting, business process consulting, and system implementation.

This partnership is part of Hitachi’s ongoing plan to strengthen solutions in the area of pharmaceutical research and development.

In a message from Hiroshi Maeda, Executive officer, Microsoft Japan:

Maeda said, “Microsoft welcomes the partnership between Hitachi, Ltd. and NextDocs Corporation as the document management solution for pharmaceutical manufacturers. NextDocs Document Management System, which runs on Microsoft Office SharePoint Server, has been adopted abroad by large pharmaceutical companies, and Japanese pharmaceutical customers’ interest in NextDocs continues to increase.” Maeda continued by saying, “Hitachi has a lot of experience in systems integration for manufacturers, and I’m convinced this partnership will accelerate the adoption of Microsoft Office SharePoint Server in the business areas of Japanese pharmaceutical customers and increase its value Microsoft will continue to create new opportunities with Hitachi.”

Source:

Hitachi, Ltd. and NextDocs Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Georgetown study raises concerns over aspirin's role in breast cancer treatment